Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $20.1100 (1.57%) ($19.6500 - $20.1600) on Tue. Mar. 6, 2018. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.79% (three month average) | RSI | 83 | Latest Price | $20.1100(1.57%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO advances 0.3% a day on average for past five trading days. | Weekly Trend | HALO advances 3.7% a week on average for past two weeks. | Market Behavior | Normal for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IBB(57%) IWO(56%) XBI(54%) IWM(51%) ARKG(50%) | Factors Impacting HALO price | HALO will decline at least -1.395% in a week (0% probabilities). UUP(-12%) VIXM(-11%) TLT(-7%) SHY(-4%) IGOV(-3%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.395% (StdDev 2.79%) | Hourly BBV | 0 () | Intraday Trend | 1.3% | | | |
|
5 Day Moving Average | $19.86(1.26%) | 10 Day Moving Average | $19.77(1.72%) | 20 Day Moving Average | $18.96(6.07%) | To recent high | -3.3% | To recent low | 17.9% | Market Cap | $2.748b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |